Managing overweight and obesity in women

Clinical Obstetrics and Gynecology

Volumn 45, Issue 4, 2002, Pages 1080-1088

  Klauer, Jana ^a   Aronne, Louis J ^a,b  

^a The Comprehensive Weight Control Program   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; AMFEBUTAMONE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; GESTAGEN; GLUCOCORTICOID; INSULIN; LITHIUM; METFORMIN; MONOAMINE OXIDASE INHIBITOR; NEUROLEPTIC AGENT; SEROTONIN UPTAKE INHIBITOR; SIBUTRAMINE; SULFONYLUREA DERIVATIVE; TETRAHYDROLIPSTATIN; TOPIRAMATE;

ABDOMINAL PAIN; BEHAVIOR THERAPY; BODY IMAGE; CONSTIPATION; DIET THERAPY; DOSE RESPONSE; EXERCISE; FECES INCONTINENCE; FEMALE; FLATULENCE; GASTROPLASTY; HEADACHE; HEALTH CARE COST; HUMAN; INSOMNIA; OBESITY; RESTLESSNESS; REVIEW; SIDE EFFECT; STOMACH BYPASS; TREATMENT PLANNING; WEIGHT GAIN; WEIGHT REDUCTION; XEROSTOMIA;

BEHAVIOR THERAPY; BODY IMAGE; BODY MASS INDEX; EXERCISE; FEMALE; HUMANS; OBESITY; WEIGHT LOSS; WOMEN'S HEALTH;

EID: 0036892602     PISSN: 00099201     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003081-200212000-00016     Document Type: Review

References (19)

1. CDC, National Health Nutrition and Exercise Study (NHANES), 1999. National Center for Health Statistics. Prevalence of Overweight and Obesity Among Adults, United States, 1999. Available at: www. cdcgov/nchs/products/pubs/pubd/hestats/obese/obse99.htm.
2. Eckel RH, Krauss RM, for the AHA Nutrition Committee. American Heart Association call to action: Obesity as a major risk factor for coronary heart disease. Circulation. 1998;97:629-660.
3. Despres JP, Kraus R. Obesity and lipoprotein metabolism. In Bray GA, Bouchard C, James WP, eds. Handbook of Obesity. New York: Marcel Dekker, 1997:651-675.
4. Lapidus L, Bengtsson C, Larson B, et al. Distribution of adipose tissue and risk of cardiovascular disease and death: A 12-year follow-up of participants in the population study of women in Gothenburg, Sweden. Br Med J (Clin Res Ed). 1984;289:1257-1261.
5. Schapira DV, Clark RA, Wolff PA, et al. Visceral obesity and the risk of breast cancer. Cancer. 1994:632-639.
6. Foster GD, Wadden TA, Phelan S, et al. Obese patients' perceptions of treatment outcomes and the factors that influence them. Arch Intern Med. 2001;161:2133-2139.
7. National Institutes of Health, National Heart Lung and Blood Institute, North American Association for the Study of Obesity. The Practical Guide: Identification, Evaluation, and Treatment of Overweight and Obesity in Adults. NIH Pub. 00-4084, 2000. Available at nhlbi.nih.gov/guidelines/obesity/practgde.pdf.
8. Wadden TA, Foster GD, Letizia KA. One-year behavioral treatment of obesity. J Consult Clin Psychol. 1994;62:165-171.
9. National Institutes of Health, National Cholesterol Education Program. Second Report of the Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). Bethesda, MD: NIH, 1993.
10. Freedman MK, King J, Kennedy, Popular diets: A scientific review. Obesity Res. 2001;1(Suppl.)1S-40S.
11. Shick SM, Wing RR, Klein ML, et al. Persons successful at long-term weight loss and maintenance continue to consume a low-energy, low-fat diet. J Am Diet Assoc. 1998;98:408-413.
12. Hu FB, Stampfer MJ, Colditz GA, et al. Physical activity and risk of stroke in women. JAMA. 2000;283:2961-2967.
13. Heim DL, Holcomb CA. Exercise mitigates the association of abdominal obesity with high-density lipoprotein cholesterol in premenopausal women. J Am Diet Assoc. 2000;100:1347-1353.
14. Stefanick ML, Mackey S, et al. Effects of diet and exercise in men and postmenopausal women with low levels of HDL cholesterol and high levels of LDL cholesterol. N Engl J Med. 1998;339:12-20.
15. Kayman S, Bruvold W, Stern JS. Maintenance and relapse after weight loss in women: Behavioral aspects. Am J Clin Nutr. 1990;52:800-7.
16. Sjostrom L, Rissanen A, et al. Randomized placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. Lancet 1998;352:167-172.
17. James WPT, Astrup A, et al. Effect of sibutramine on weight maintenance after weight loss. Lancet. 2000;356:2119-2125.
18. Roy Chengappa KN, Levine J, et al. Long-term effects of topiramate on bipolar mood instability, weight change and glycemic control. Eur Psychiatry. 2001;16:186-190.
19. Gadde KM, Parker CB, Maner LG, et al. Bupropion for weight loss. Obesity Res. 2001;9:544-551.